Plus, new insights into metastatic cancer and tips for caregivers.
If you have trouble viewing this email, view it online.
connect with us 
FDA Opens the Door to More-Personalized Medicine
The FDA recently authorized MSK-IMPACT™, a test that looks for genetic mutations in tumors. By identifying those errors, doctors may be able to give people more-customized treatments.
Learn more
Personalize Your Updates
Get only the MSK news you want. If you tell us what you’re interested in, we will send you the updates you want to read.
Go to my preferences
Toward Better Treatments for Cancer Metastasis
Joan Massagué, Director of MSK’s Sloan Kettering Institute, explains how he and his team are tackling advanced cancer.
Discover their approach

Answering Your Questions about Stage IV Cancer
There are a number of treatments for metastatic cancer. We’re here to help you make sense of your options.
Hear from our experts
Give to MSK
With your support, we’ll see a 2018 brimming with even more breakthrough innovations. There are many ways to make a difference this holiday season.
Visit to learn more
The Buzz at MSK
2017: A Year of Innovation
Take a look back at some of the most exciting developments in the field of cancer research this year.
Read more
Tips on Caring for a Loved One — and for Yourself
Current and former MSK caregivers offer up their best advice for handling the responsibility.
Read more
What Can Genes Tell Us about Immunotherapy?
They might offer clues as to why it doesn’t yet work in everybody, explains MSK physician-scientist Timothy Chan.
Read more
Contact Us
We welcome your feedback, and encourage you to send us a message at:
Helpful Resources
To Make an Appointment:
To Reach Us by Phone:
Find an MSK location
©2017 Memorial Sloan Kettering Cancer Center
1275 York Ave., New York, NY 10065 US

December 2017